← Back
$TSHA All transactions

Taysha Gene Therapies, Inc.

▼ SELL

$ Value

$375K

Shares

78,968

Price

$5

Filed

Jan 27

Insider

Name

Alam Kamran

Title

CHIEF FINANCIAL OFFICER

CIK

0001793412

Roles

Officer

Transaction Details

Transaction Date

2026-01-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,467,635

Footnotes

The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive.

Filing Info

Accession No.

0001793412-26-000008

Form Type

4

Issuer CIK

0001806310

Alam Kamran's History

Date Ticker Type Value
2026-02-04 TSHA $7K
2026-01-26 TSHA $110K
2026-01-23 TSHA $375K
2026-01-12 TSHA A $0
2026-01-12 TSHA A $0
2025-08-21 TSHA $155K

Other Insiders at TSHA (90d)

Insider Bought Sold Last
Nolan Sean P.
Chief Executive Officer
$840K 2026-01-26
Nagendran Sukumar
President and Head of R&D
$1.4M 2026-04-10
Alam Kamran
CHIEF FINANCIAL OFFICER
$117K 2026-02-04